Press Release
April 13, 2020
Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
More
April 9, 2020
Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
More
March 12, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019
More
March 5, 2020
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020
More
February 27, 2020
Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL
More
January 28, 2020
Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
More
November 27, 2019
Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference
More
November 15, 2019
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
More
November 7, 2019
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019
More
November 1, 2019